Default object view. Click to create a custom template, Node ID: 104789, Object ID: 62747

Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or pr...

Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial

No relation

Yes

No relation

No

18/03/2015 11:40 am

No